Neurotech Notables #34: June 16-30, 2025
☀️Summertime, when the living's EEG🎧
Greetings, Readers, and welcome to the third quarter.
Despite the summer slowdown and ongoing uncertainty in the headlines, neurotech’s dynamism and steady evolution continue drawing interest in local news, niche networks, national media, and the global stage. Here’s what’s new over the last two weeks:
New funding in venture checks and research grants continues to trickle in. Stay tuned for a first-half-of-’25 funding tally
US federal funding for science & technology remains uncertain despite continued solicitations for grant applications. It’s no surprise then that research centers and programs continue to emerge, led by academic institutions, private backers, and overseas governments alike.
A fleet of prominent regulatory headlines emerged along with new executive appointments. Notable company updates include an acquisition, a rebrand, and two shutdowns.
Meanwhile, neuroethics discussions ascend to the global stage, while the neurorights movement gains national buy-in with the AMA’s seeming endorsement. But to what end?
Industry awards, new publications, and plenty of videos await you below...
On a personal note: I’m wrapping up a period of personal leave before diving back into all things neurotech this summer, from a backlog of articles to picking up strategic projects. If I’ve yet to return your message, I promise I will get to it very soon. If you are interested in partnerships, sponsorships, or other collaborations, send me your ideas!
👋🏽 Hi, I’m Naveen. I believe brain health is human health. You are one of the 2,600 readers of my biweekly reports on emerging neurotech markets.
Here are five ways to support my work: 1. click “❤️” to amplify 2. share for perks 3. buy me coffee 4. become a partner 5. 🆕 post a job (beta)
📲 connect and collaborate with me here: email | LinkedIn | X | bluesky
NANS
NANS joins 74 medical organizations in urging Senate to protect access to care for Medicare Beneficiaries (NANS)
TTP
Reimagining tinnitus therapy: a non-invasive neurostimulator designed for everyday use - Read more
Datwyler
Open Position: BD Manager, Wearable Sensors based in Ontario, California - Read more
Card79
Thought based interfaces: “A Day in the Mind”- Read More
Funding
Neurable has secured strategic investment from Ascendo Venture Capital (LinkedIn)
SCI Ventures invests $2m in Healx for AI drug discovery for paralysis (BusinessWeekly)
Cenexum Technologies and partners secure €2.3 million investment from Innovation Fund Denmark for epilepsy brainchip (LinkedIn)
Richard Price, PhD, and John Lukens, PhD, Awarded $3.7 Million for Alzheimer’s Research Using Focused Ultrasound (UVA)
National Institutes of Health (NIH) re-issues NOFO for neurotech translation through the Blueprint MedTech UG3/UH3 program (NIH)
Aging Brain Initiative seed grants fund five new projects to address neurodegenerative disease (MIT)
Commercial
Ampa Health partners with partners with Southern California TMS Center (LinkedIn)
Drive DeVilbiss Healthcare acquires product line of De Oro Devices (HME News)
Nexstim Plc Signs Exclusivity Agreement with Sinaptica Therapeutics, Inc. as Part of Planned Alzheimer's Collaboration (Nexstim)
Saluda Medical Appoints Barry Regan as Chief Executive Officer (PR Newswire)
Avivomed Names Dan Brounstein as Next Chief Executive Officer (PR Newswire)
Inner Cosmos brings Intuitive co-founder onto board (MassDevice)
Nervonik hires Ranjan Nageri as Senior Director of Engineering and Supply Chain (LinkedIn)
ActiGraph officially rebrands as Ametris (Ametris)
Neurotype announces first US patent (LinkedIn)
Elemind crosses $2M in top-line revenue in first year of sales (LinkedIn)
NeoSensory Closes Down (LinkedIn)
BrightMind.AI announces insolvency (LinkedIn)
Bioness Medical Announces Acquisition of the Assets and Business of Harmonic Bionics (PR Newswire)
Regulatory
FDA approves Neuspera’s integrated sacral neuromodulation system for urinary urge incontinence (Urology Times)
Science Submits CE Mark Application for PRIMA Retinal Implant – A Critical Step Towards Making It Available To Patients (Science)
ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application (Onward)
MCRA Assists Epiminder with FDA De Novo Approval for Minder, the First Implantable, Continuous EEG Monitor for Epilepsy (MCRA)
Sora Neuroscience Announces FDA Clearance of Cirrus Resting State fMRI Brain Mapping Software (EIN Presswire)
Brain Navi wins FDA nod for neurosurgical robot (MassDevice)
Cerevasc gains Health Canada approval for STRIDE trial (NeuroNews)
Health Plans Take Action to Simplify Prior Authorization (AHIP)
I’m not optimistic that this will lead to any changes. Your thoughts?
Industry
Precision Neuroscience Named to Fast Company’s World Changing Ideas and Inc.’s Best Workplaces Lists (GlobeNewswire)
INBRAIN Neuroelectronics Named 2025 World Economic Forum Technology Pioneer (BusinessWire)
Medical Research Council announces new Centre of Research Excellence (MRC CoRE) that will develop brain stimulation devices to treat conditions such as Parkinson’s, dementia and childhood epilepsy (LinkedIn)
Corporate Plan, Building for Breakthroughs (ARIA)
Corundum Convergence Institute and the University of Tokyo's International Research Center for Neurointelligence Launch Inaugural Neuroscience Entrepreneurship Workshop (PR Newswire)
Consensus Guidelines from the American Society of Pain and Neuroscience for the Use of 60-Day Peripheral Nerve Stimulation Therapy. A NEURON Living Guideline Project (JPR)
Click, speak, move: These brain implants are poised to help people with disabilities (NPR)
The startups bringing brain-computer interfaces to market (Marketplace)
Next-Gen Brain Implants Offer New Hope for Depression (IEEE)
European start-up challenges Neuralink’s Blindsight device (Columbia News Online)
SCI: Implant can offer hope to survivors (Dallas News)
Recap: Night of Neurotech (PsyMed Ventures)
Recap: Neuroworks Cambridge event (Hannah Claridge)
SynchNeuro: A Neurosurgeon's Surprising Leap into Cardiometabolic Care (Startup Health)
Sinaptica: Publication in Alzheimer’s & Dementia Elucidates Multimodal Mechanism of Action Underpinning Promising New Neuromodulation Therapy for Alzheimer’s (BusinessWire)
Connecticut Passes Law to Establish $2 Million Center of Excellence to Provide Veterans with Access to FDA-Approved Vivistim Therapy for Stroke Recovery (PR Newswire)
Rewriting the Timeline of Detection: Linus Health's Digital Platform Uncovers the Earliest Signs of Cognitive Decline (PRNewswire)
Exomind from Health 419: New device to treat depression, promote mental wellness, debuts in Northwest Ohio (WTVG 13)
Morning Coffee with Bradley Treeby, Co-Founder and CEO of NeuroHarmonics (SpeedInvest)
SharperSense: Transcutaneous Cervical Vagus Nerve Stimulation Improves Speech Comprehension in Noise: A Crossover, Placebo-Controlled Study (Neuromodulation)
Sona: a new closed-loop, VNS device that’s built to support not just HRV, but also neuroplasticity and long-term nervous system resilience (Sona)
Sound Startups for the Brain and Mind (BrainMind)
Neurotech.TV
Neuralink Update, Summer 2025 (Neuralink)
Meet Four of Neuralink’s trial participants (Barrow)
Is Neurotechnology Redefining Wellbeing? Tom Oxley & Hoda Al Khzaimi (World Economic Forum)
2025 American Brain Coalition BRAIN Briefing (ABC)
The Davos Brain House Video: A global call to prioritize brain health (Davos Alzheimer’s Collaborative)
International Markets: Global Brain Health Challenges and Strategies (Business for Brain Health)
Fixing American Science Funding (Core Memory)
Nicole Rust on her new book, ‘Elusive Cures’ (The Transmitter)
Revolutionizing Early Alzheimer's Diagnosis: Cx Precision Medicine's Impact on Primary Care (Startup Health)
Webinar: Neuroarts Resource Center Walkthrough (Neuroarts Resource Center)
Society
American Medical Association Unanimously Adopts Resolution both defining neural data collected by neurotechnologies and supporting regulatory efforts to protect privacy & security (Neurorights Foundation)
The AMA manages the business side of CPT codes. Will this new resolution have negative consequences for the industry? Will they have the intended positive consequences for society? What do you think?
UNESCO’s Recommendation on Neurotechnology: realizing the rights of people with mental disabilities (Nature)
Unveiling the Human Stories Behind Brain Implants (Georgia Tech)
The Dark Side of Cognitive Enhancement: a Framework for the Technologically-Induced Cognitive Diminishment (SSRN)
An introduction to Neurocolonialism -A Challenge for Emerging Economies like Nigeria (ResearchGate)
Meta boss praises new US army division enlisting tech execs as lieutenant colonels (Guardian)
Research
Medical Research Council announces new Centre of Research Excellence (MRC CoRE) that will develop brain stimulation devices to treat conditions such as Parkinson’s, dementia and childhood epilepsy (LinkedIn)
Georgia Tech Launches Two New Interdisciplinary Research Institutes (Georgia Tech)
Transdiagnostic neuromodulation of impulsivity: current status and future trajectories (Translational Psychiatry)
Machine Learning for the Segmentation of Different Nerve Fibre Activations from Brain-to-body Neural Signals (Mila)
Global Outcomes of Traumatic Brain Injury Across Human Development Index Strata: A Multi-Center, International, Prospective Cohort Study (Lancet)
Publication in Alzheimer’s & Dementia Elucidates Multimodal Mechanism of Action Underpinning Promising New Neuromodulation Therapy for Alzheimer’s (Business Wire)
Large-scale high-density brain-wide neural recording in nonhuman primates (Nature Neuroscience | Commentary)
“In the present report, we describe the design, fabrication and performance of Neuropixels 1.0 NHP, a high-channel electrode array designed to enable large-scale acute recording throughout large animal brains.”
Neurons throughout the brain embed robust signatures of their anatomical location into spike trains (eLife)
Resource utilization and economic outcomes following repetitive transcranial magnetic stimulation for treatment-resistant depression: a retrospective observational analysis (JCER)
“This study suggests that rTMS for Treatment-Resistant Depression may diminish high acuity encounters and reduce Episode of Care costs for at least 18 months after the index treatment.”
Source: Taylor et al, 2025, Journal of Comparative Effectiveness Research
Loved it? Please click “❤️” to amplify brain health innovations for everyone.
📲 connect and collaborate with me here! email | LinkedIn | X | bluesky